Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

4.40
Delayed Data
As of Oct 23
 +0.20 / +4.76%
Today’s Change
2.00
Today|||52-Week Range
6.30
+46.67%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close4.20
Today’s open4.25
Day’s range4.20 - 4.55
Volume558,446
Average volume (3 months)650,287
Market cap$137.9M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+47.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.03+0.74%
TRVNTrevena Inc-0.16-9.09%
REPHRecro Pharma Inc-0.15-1.67%
MDWDMediwound Ltd+0.10+2.00%
Data as of 3:59pm ET, 10/23/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts